JPRN-UMIN000012401已完成未知
Assessment of safety and initial therapeutic efficacy of non-damaging patterned scanning laser phototherapy in patients with diffuse diabetic macular edema - safety and efficacy of patterned scanning laser phototherapy in patients with diffuse diabetic macular edema
agoya City University Gradate School of Medical Sciences0 个研究点目标入组 10 人开始时间: 2013年12月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Eyes with scatter photocoagulation (PRP) one month prior the enrollment, or eyes where scatter photocoagulation is required now, or it likely to be needed over the next 6months. Presence of any abnormality that is likely to confound the assessment of the improvement in visual acuity in eyes with macular edema to resolve or improve as an area of hard exudates involving the foveal avascular zone, epiretinal membrane associated with signs of contraction and / or significant opacification, or the presence of chorioretinal atrophy involving the center of the macula. Vitreomacular traction determined clinically and / or OCT, which in the opinion of the investigator, contributes to macular edema and prevents the improvement with treatment. Any cause of macular edema other than DME. Atrophy / scar / fibrosis involving the center of the macula, including evidence of atrophy treated with laser within 200 microns of the FAZ. Patients who received panphotocoagulation, YAG laser, or peripheral retinal cryoablation (for retinal tears) or focal or grid photocoagulation within the last 12 weeks or more of treatment with focal or grid laser. Significant opacities of the optical medium, including cataracts, which may interfere with visual acuity, assessment of toxicity or photography background. Patients will not be included if they have high probability of requiring cataract surgery within the next year. Any intraocular surgery within 6 months prior to study entry. Prior peeling of ERM or ILM. Any major surgical procedure within one month of study entry Prior irradiation of the head region of the eye under study. Any previous pharmacological treatment for DME or at any time during the last 90 days for any other condition. Important known allergies to sodium fluorescein dye used in angiography. Acute ocular or periocular infection.
研究者
相似试验
招募中
2 期
Therapeutic effect of dalfampridine on patients with Devic syndromeDevic.Neuromyelitis optica [Devic]G36.0IRCT20210917052506N1Esfahan University of Medical Sciences70
已完成
4 期
Evaluation of the therapeutic efficacy and safety of pyronaridine-artesunate for the treatment of uncomplicated falciparum malaria in areas of artemisinin-resistant falciparum malaria in Viet NamACTRN12618001274268Ministry of Health, Viet Nam153
尚未招募
2 期
Preliminary evaluation of the efficacy and safety of Xuezhikang tablets (LY02404) in the treatment of hyperlipidemia: a multicenter, randomized, double-blind, double-simulation, parallel control of positive drugs, and dose-exploration phase II clinical trialITMCTR2000003402Peking University First Hospital
进行中（未招募）
1 期
Evaluation of treatment effectiveness and safety of somatic cell based therapy for urinary incontinence in patients after radical prostatectomy.urinary incontinenceMedDRA version: 20.0Level: LLTClassification code: 10021643Term: Incontinence urinary Class: 10038359CTIS2023-509812-27-00icolaus Copernicus University45
已完成
不适用
Evaluation of efficacy and safety after treatment of twice daily mixed insulin analogue in patients with type 2 diabetesEndocrine, nutritional and metabolic diseaseKCT0000388Inje University Sanggye Paik Hospital60